A resourceful giant: APMV is able to interfere with the human type I interferon system

Microbes and Infection

Volumn 16, Issue 3, 2014, Pages 187-195

  Silva, Lorena C F ^a   Almeida, Gabriel M F ^a   Oliveira, Danilo B ^a   Dornas, Fábio P ^a   Campos, Rafael K ^a   La Scola, Bernard ^b   Ferreira, Paulo C P ^a   Kroon, Erna G ^a   Abrahão, Jônatas S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Interferon; Mimiviridae; PBMCs; Phagocytes

Indexed keywords

ALPHA2 INTERFERON; BETA1 INTERFERON; INTERFERON;

ACANTHAMOEBA POLYPHAGA MIMIVIRUS; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; MIMIVIRUS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS INFECTION; VIRUS REPLICATION;

ACANTHAMOEBA POLYPHAGA MIMIVIRUS; MURINAE; VERTEBRATA;

INTERFERON; MIMIVIRIDAE; PBMCS; PHAGOCYTES;

CELLS, CULTURED; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERON TYPE I; LEUKOCYTES, MONONUCLEAR; MIMIVIRIDAE; STAT TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 84896388805     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.11.011     Document Type: Article

References (37)

1. La Scola B., Audic S., Robert C., Jungang L., de Lamballerie X., Drancourt M., et al. A giant virus in amoebae. Science 2003, 299:2033.
2. Boyer M., Madoui M.A., Gimenez G., La Scola B., Raoult D. Phylogenetic and phyletic studies of informational genes in genomes highlight existence of a 4th domain of life including giant viruses. PLoS One 2010, 5:1-8.
3. Moreira D., Brochier-Armanet C. Giant viruses, giant chimeras: the multiple evolutionary histories of mimivirus genes. BMC Evol Biol 8 2008, 1-10.
4. Monier A., Larsen J.B., Sandaa R.A., Bratbak G., Claverie J.M., Ogata H. Marine mimivirus relatives are probably large algal viruses. Virol J 2008, 5:1-8.
5. Ghedin E., Claverie J.M. Mimivirus relatives in the Sargasso sea. Virol J 2005, 2:62-69.
6. Raoult D., Audic S., Robert C., Abergel C., Renesto P., Ogata H., et al. The 1.2-megabase genome sequence of mimivirus. Science 2004, 306:1344-1350.
7. Claverie J.M., Abergel C. Mimivirus: the emerging paradox of quasiautonomous viruses. Trends Genet 2010, 26:431-437.
8. Greub G., Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004, 17:413-433.
9. Raoult D., La Scola B., Birtles R. The discovery and characterization of mimivirus the largest known virus and putative pneumonia agent. Clin. Infect. Dis 2007, 45:95-102.
10. La Scola B., Marrie T.J., Auffray J.P., Raoult D. Mimivirus in pneumonia patients. Emerg Infect Dis 2005, 11:449-452.
11. Dare R.K., Chittaganpitch M., Erdman D.D. Screening pneumonia patients for mimivirus. Emerg Infect Dis 2008, 14:465-467.
12. Larcher C., Jeller V., Fischer H., Huemer P. Prevalence of respiratory viruses, including newly identified viruses, in hospitalized children in Austria. Eur J Clin Microbiol Infect Dis 2006, 25:681-686.
13. Vanspauwen M.J., Franssen F.M.E., Raoult D., Wouters E.F.M., Bruggeman C.A., Linssen C.F. Infections with mimivirus in patients with chronic obstructive pulmonary disease. Respir Med 2012, 12:1690-1694.
14. Ghigo E., Kartenbeck J., Lien P., Pelkmans L., Capo C., Mege J.L., et al. Ameobal pathogen mimivirus infects macrophages through phagocytosis. PLoS Pathog 2008, 4. e1000087.
15. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007, 6:975-990.
16. Samarajiwa S.A., Forster S., Auchettl K., Hertzog P.J. Interferome: the database of interferon regulated genes. Nucleic Acids Res 2009, 37:852-857.
17. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc R Soc London B Biol Sci 1957, 47:258-267.
18. Bonjardim C.A., Ferreira P.C., Kroon E.G. Interferons: signaling, antiviral and viral evasion. Immunol Lett 2009, 122:1-11.
19. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in détente. Science 2006, 312:879-882.
20. Levy D.E., Marié I.J., Durbin J.E. Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol 2011, 1:476-486.
21. Perdiguero B., Esteban M. The interferon system and Vaccinia virus evasion mechanisms. J Interferon Cytokine Res 2009, 20:581-598.
22. Reed L.J., Muench H. A simple method of estimating fifty per cent end points. Am J Hyg 1938, 27:493-497.
23. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 1968, 97:77-89.
24. Martins R.M. J. Rodriguez dos Santos, R.R. Golgher, Mill Hill strain of parainfluenza 1 virus is a potent human interferon inducer. J Interferon Res 1989, 9:379-383.
25. Ferreira P.C., Peixoto M.L., Silva M.A., Golgher R.R. Assay of human interferon in Vero cells by several methods. J Clin Microbiol 1979, 9:471-475.
26. Marques J.T., Trindade G.D., Da Fonseca F.G., Dos Santos J.R., Bonjardim C.A., Ferreira P.C., et al. Characterization of ATI, TK and IFN-alpha/betaR genes in the genome of the BeAn 58058 virus, a naturally attenuated wild Orthopoxvirus. Virus Genes 2001, 23:291-301.
27. Almeida G.M., de Oliveira D.B., Magalhães C.L., Bonjardim C.A., Ferreira P.C., Kroon E.G. Antiviral activity of type I interferons and interleukins 29 and 28a (type III interferons) against Apeu virus. Antiviral Res 2008, 80:302-308.
28. Mann B.A., Huang J.H., Li P., Chang H.C., Slee R.B., O'Sullivan A., et al. Vaccinia virus blocks stat1-dependent and stat1-independent gene expression induced by type I and type II interferons. J Interferon Cytokine Res 2008, 28:367-380.
29. Symons J.A., Alcamí A., Smith G.L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 1995, 81:551-560.
30. Waibler Z., Anzaghe M., Frenz T., Schwantes A., Pöhlmann C., Ludwig H., et al. Components interferon receptor B18 and intracellular process involving the soluble type I interferon responses is a multifactorial. Vaccinia J Viro 2009, 83:1563-1571.
31. Holzinger D., Jorns C., Stertz S., Boisson-Dupuis S., Thimme R., Weidmann M., et al. Induction of MXA gene expression by Influenza A virus requires type I or type III interferon signaling. J Virol 2007, 81:7776-7785.
32. Marijanovic Z., Ragimbeau J., van der Heyden J., Uzé G., Pellegrini S. Comparable potency of IFN α2 and IFN β on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem. J. 2007, 407:141-151.
33. Hillyer P., Mane V.P., Schramm L.M., Puig M., Verthelyi D., Chen A., et al. Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol Cell Biol 2012, 90:774-783.
34. Moraga I., Harari D., Schreiber G., Uzé G., Pellegrini S. Receptor density is key to the alpha2/beta interferon differential activities. Mol Cell Biol 2009, 29:4778-4787.
35. Francois-Newton V., Livingstone M., Payelle-Brogard B., Uzé G., Pellegrini S. USP18 establishes the transcriptional and anti-proliferative interferon α/β differential. Biochem J 2012, 446:509-516.
36. de Weerd N.A., Vivian J.P., Nguyen T.K., Mangan N.E., Gould J.A., Braniff S.J., et al. Structural basis of a unique interferon-b signaling axis mediated via the receptor IFNAR1. Nat Immunol 2013, 14:901-907.
37. Boyer M., Azza S., Barrassi L., Klose T., Campocasso A., Pagnier I., et al. Mimivirus shows dramatic genome reduction after intraamoebal culture. Proc Natl Acad Sci U S A 2011, 108:10296-10301.